Infectious Diseasescommunity-acquired pneumoniaglucocorticoids
Adjunctive Low-Dose Glucocorticoids Reduce Mortality in Community-Acquired Pneumonia in Low-Resource Settings: Evidence from a Kenyan Pragmatic Trial
By MedXY|Oct 31, 2025
A pragmatic randomized trial in Kenyan public hospitals demonstrates that adjunctive low-dose glucocorticoid therapy significantly reduces 30-day mortality in adults with community-acquired pneumonia without increasing serious adverse event
